Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

50
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
50
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

90
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
90
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

263
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
263
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

59
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
59

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial Intelligence in Peritoneal Dialysis: Applications, Algorithms, and Future Directions.

Blood purification·2026
Same author

Cytokine Profiles in Patients with Chronic Kidney Disease and Low Sexual Function.

American journal of physiology. Renal physiology·2026
Same author

Protocol-constrained AI enhances tacrolimus dosing accuracy in kidney transplant care.

Frontiers in artificial intelligence·2026
Same author

Generative AI and large language model evaluation of kidney donation websites: Benchmarking health literacy, sentiment, and digital engagement to optimize donor recruitment.

Digital health·2026
Same author

Sex hormones and sexual health in chronic kidney disease before and after kidney transplantation.

Journal of nephrology·2026
Same author

Intensive Hemodialysis Versus Kidney Transplantation: Is there Equipoise Regarding Optimal Pregnancy Management?

Kidney international reports·2026

Related Experiment Video

Updated: Sep 18, 2025

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

7.5K

Navigating the Complexities of Cancer Treatment-Induced Hypertension.

Jose Arriola-Montenegro1, John Roth2, Maria L Gonzalez Suarez1

  • 1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.

Journal of Cardiovascular Development and Disease
|June 25, 2025
PubMed
Summary

Cancer therapy-induced hypertension (HTN) is a growing concern with various cancer treatments. Management requires individualized plans and a multidisciplinary approach for optimal patient outcomes.

Keywords:
VEGFcancerhypertensiononconephrology

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.5K
Author Spotlight: Computing the Effects of a Local Radiofrequency Hyperthermia Intervention on Tumor Biomechanics
10:23

Author Spotlight: Computing the Effects of a Local Radiofrequency Hyperthermia Intervention on Tumor Biomechanics

Published on: December 1, 2023

563

Related Experiment Videos

Last Updated: Sep 18, 2025

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

7.5K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.5K
Author Spotlight: Computing the Effects of a Local Radiofrequency Hyperthermia Intervention on Tumor Biomechanics
10:23

Author Spotlight: Computing the Effects of a Local Radiofrequency Hyperthermia Intervention on Tumor Biomechanics

Published on: December 1, 2023

563

Area of Science:

  • Oncology
  • Cardiology
  • Pharmacology

Background:

  • Cancer therapy-induced hypertension (HTN) is a frequent complication of diverse anticancer agents, including VEGF inhibitors and tyrosine kinase inhibitors.
  • Pathogenesis involves multifactorial mechanisms like endothelial dysfunction, nitric oxide suppression, and sympathetic activation.
  • Coexisting factors such as pain, mood disturbances, and cardiovascular risks complicate HTN management in cancer patients.

Purpose of the Study:

  • To review the mechanisms, diagnosis, and management of cancer therapy-induced HTN.
  • To highlight the limitations of current general guidelines and the need for oncology-specific protocols.
  • To emphasize the importance of accurate blood pressure monitoring and tailored treatment strategies.

Main Methods:

  • Literature review of mechanisms and clinical implications of cancer therapy-induced HTN.
  • Analysis of current management strategies and available antihypertensive agents.
  • Discussion of the role of a multidisciplinary approach in patient care.

Main Results:

  • Cancer therapy-induced HTN is linked to agents like VEGF inhibitors, proteasome inhibitors, and TKIs.
  • Endothelial dysfunction, NO suppression, and sympathetic activation are key pathogenic mechanisms.
  • ACE inhibitors, ARBs, and calcium channel blockers demonstrate efficacy in blood pressure control and potentially oncologic outcomes.

Conclusions:

  • Cancer therapy-induced HTN necessitates individualized management beyond general guidelines.
  • Accurate blood pressure monitoring and prompt intervention are crucial for optimizing cancer treatment and patient outcomes.
  • A collaborative, multidisciplinary approach is essential for effectively managing this complex condition.